Is your pharmacovigilance business continuity plan adapted to the current risk landscape?

At PharmAdvice, we review our business continuity plan (BCP) annually. But prompted by recent international events, we have given it a comprehensive re-evaluation to ensure it’s aligned with all relevant risks and threats.